Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antiseptic Mouth Rinses for SARS-CoV-2 Viral Load Reduction
NCT04707742Completed
- Start
- Jun 2020
- Primary completion
- Sep 2021
- Modality
- Conventional Liposomes, Small Molecules
- Countries
- 1
01
Overview
Randomised, single-blind trial of povidone-iodine, hydrogen peroxide, chlorhexidine and cetylpyridinium chloride in coronavirus disease 2019 (COVID-19) (5 arms). Primary endpoints: Change in salivary viral load of SARS-CoV-2 and Infective SARS-CoV-2 viral load in saliva. Started Jun 2020; status: completed.
02
Drugs
povidone-iodinehydrogen peroxidechlorhexidinecetylpyridinium chloride
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04707742.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04707742.